The Joint Corp. (JYNT)

NASDAQ: JYNT · Real-Time Price · USD
8.72
+0.05 (0.58%)
At close: May 8, 2026, 4:00 PM EDT
8.69
-0.03 (-0.34%)
After-hours: May 8, 2026, 4:10 PM EDT
Market Cap123.99M -21.4%
Revenue (ttm)56.64M +7.3%
Net Income3.24M
EPS0.21
Shares Out 14.27M
PE Ratio100.57
Forward PE14.73
Dividendn/a
Ex-Dividend Daten/a
Volume86,855
Open9.08
Previous Close8.67
Day's Range8.70 - 9.19
52-Week Range7.50 - 13.47
Beta1.11
AnalystsStrong Buy
Price Target17.00 (+94.95%)
Earnings DateMay 7, 2026

About JYNT

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Sector Healthcare
IPO Date Nov 11, 2014
Employees 330
Stock Exchange NASDAQ
Ticker Symbol JYNT
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for JYNT stock is "Strong Buy." The 12-month stock price target is $17.0, which is an increase of 94.95% from the latest price.

Price Target
$17.0
(94.95% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

The Joint Earnings Call Transcript: Q1 2026

Revenue grew 13% year-over-year to $14.8M, with adjusted EBITDA from continuing operations up sharply and net income turning positive. Major refranchising is nearly complete, transforming the business into a pure-play franchisor, with improved profitability and strong cash flow supporting share repurchases.

3 days ago - Transcripts

The Joint Corp. Reports First Quarter 2026 Financial Results

- First Quarter Revenues Grew 13%, Net Income Rose 34% and Adjusted EBITDA Increased 22% Year over Year - - Repurchased $1.1 Million of Shares - SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- The...

3 days ago - GlobeNewsWire

Joint Corp. to sell 45 corporate managed clinics to Elite Chiro for $2.3M

Joint Corp. (JYNT) announced that it has signed an asset purchase agreement effective on April 20 for the sale of 45 corporate managed clinics in Southern California to Elite Chiro

13 days ago - TheFly

The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California

- Effectively Positions The Joint as a Pure-play Franchisor - SCOTTSDALE, Ariz., April 27, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (the “Company”), the nation's largest franchisor of c...

13 days ago - GlobeNewsWire

The Joint Chiropractic® Names Michelle Reap as Director of Franchise Development

Experienced franchise executive joins the nation's largest chiropractic care network to align its next phase of growth SCOTTSDALE, Ariz., April 14, 2026 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT),...

26 days ago - PRNewsWire

The Joint Chiropractic and Subaru of Utah Partner to Bring Chiropractic Care to over 275 Employees

New agreement offers Miller Subaru employees in Utah access to preferred pricing on The Joint's already affordable care model across participating locations, expanding their existing wellness offering...

4 weeks ago - PRNewsWire

Joint Corp. price target lowered to $12 from $14 at Roth Capital

Roth Capital lowered the firm’s price target on Joint Corp. (JYNT) to $12 from $14 and keeps a Buy rating on the shares. The company’s Q4 results exceeded estimates while

2 months ago - TheFly

The Joint Earnings Call Transcript: Q4 2025

Revenue and adjusted EBITDA grew in Q4 2025, driven by cost optimization and refranchising progress. Marketing and pricing initiatives are underway to boost new patient acquisition, with 2026 guidance projecting stable to modestly higher sales and profitability.

2 months ago - Transcripts

The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast

SCOTTSDALE, Ariz., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announced it will rep...

2 months ago - GlobeNewsWire

The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience

Brings more than 30 Years of Operational Enhancement Success for Leading Franchisors Across Multiple Industries Brings more than 30 Years of Operational Enhancement Success for Leading Franchisors Acr...

4 months ago - GlobeNewsWire

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

Southeast Buyers are Existing Members of the Franchise Community, Further Increasing their Ownership Southeast Buyers are Existing Members of the Franchise Community, Further Increasing their Ownershi...

5 months ago - GlobeNewsWire

Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals"

SCOTTSDALE, Ariz. , Nov. 17, 2025 /PRNewswire/ -- The holidays can feel like a full-contact sport for your back.

6 months ago - PRNewsWire

Joint Corp. price target lowered to $14 from $15 at Roth Capital

Roth Capital lowered the firm’s price target on Joint Corp. (JYNT) to $14 from $15 and keeps a Buy rating on the shares after its Q3 results. Refranchising process continues

6 months ago - TheFly

Joint Corp. price target lowered to $11 from $16 at Lake Street

Lake Street analyst Ryan Meyers lowered the firm’s price target on Joint Corp. (JYNT) to $11 from $16 and keeps a Buy rating on the shares. The transition toward a

6 months ago - TheFly

Joint Corp. downgraded to Neutral from Buy at B. Riley

B. Riley downgraded Joint Corp. (JYNT) to Neutral from Buy with a price target of $9, down from $18. The company’s Q3 comps were down 2.0%, reflecting continued softness in

6 months ago - TheFly

The Joint Earnings Call Transcript: Q3 2025

Revenue and Adjusted EBITDA grew year-over-year, driven by cost optimization and refranchising, despite a decline in system-wide and comp sales. National marketing, pricing pilots, and technology upgrades aim to boost new patient growth and profitability.

6 months ago - Transcripts

Joint Corp. board authorizes additional $12M share repurchase program

The Joint Corp. (JYNT) announced that its board of directors has authorized an additional $12 million for its stock repurchase program. “We are executing on our plan to reignite growth

6 months ago - TheFly

The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List

SCOTTSDALE, Ariz. , Oct. 7, 2025 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has been recognized on the ...

7 months ago - PRNewsWire

The Joint Chiropractic Debuts in Delaware

-First Location Now Open in Dover- SCOTTSDALE, Ariz. , Oct. 3, 2025 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® n...

7 months ago - PRNewsWire

Joint Corp. appoints Debbie Gonzalez Chief Marketing Officer

The Joint Corp. (JYNT) announced that Debbie Gonzalez joined as Chief Marketing Officer, effective October 7, replacing Lori Abou Habib. Most recently, Gonzalez was CMO/SVP, Global Marketing and Commu...

7 months ago - TheFly

The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer

- CMO with extensive experience in brand building, franchising and strategic growth – - CMO with extensive experience in brand building, franchising and strategic growth –

7 months ago - GlobeNewsWire

The Joint Earnings Call Transcript: Q2 2025

Q2 saw refranchising of 37 clinics, 5% revenue growth, and a 52% rise in adjusted EBITDA. Guidance for 2025 was revised downward for sales but raised for adjusted EBITDA, reflecting macro headwinds and cost discipline. Cash position strengthened and a $5M share buyback was authorized.

9 months ago - Transcripts

The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges

- Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million,...

10 months ago - GlobeNewsWire

The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results

SCOTTSDALE, Ariz., July 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will repo...

10 months ago - GlobeNewsWire

Joint Corp. closes sale of 31 corporate clinics in Arizona, New Mexico

The Joint Corp. (JYNT) closed the sale of 31 corporate owned and managed clinics and associated franchise licenses in Arizona and New Mexico to Joint Ventures in exchange for $8.3M

10 months ago - TheFly